Don’t forget the contribution of medicines to oral health

1. Wright FAC, Law G, Chu SK, et al. Residential age care and domiciliary oral health services: Reach-OHT-The development of a metropolitan oral health programme in Sydney, Australia. Gerodontology 2017;34(4):420–26.

2. Beckett DM, Meldrum AM. Factors that influence inequity of oral health in New Zealand and what we can do about them. In Duncanson M, Oben G, Adams J, et al. (Eds). Health and wellbeing of under-five year olds in New Zealand 2017 (pp. 121–38). Dunedin, NZ: New Zealand Child and Youth Epidemiology Service; 2019. http://hdl.handle.net/10523/8795

3. Lacey JK, Thomson WM, Crampton P, et al. Working towards Māori oral health equity: Why te Tiriti o Waitangi needs to underpin the oral health system, using evidence from the New Zealand Oral Health Survey. NZ Dental Journal 2021;117(3):105–10. https://www.nzda.org.nz/about-us/new-zealand-dental-journal-articles/nzdj-2021

4. Wolff A, Joshi RK, Ekström J, et al. A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: A systematic review sponsored by the World Workshop on Oral Medicine VI. Drugs R D 2017;17(1):1–28.

5. Yohannes AM, Connolly MJ, Hanania NA. Ten years of tiotropium: clinical impact and patient perspectives. Int J Chron Obstruct Pulmon Dis 2013;8:117–25.

6. Yuan A, Woo SB. Adverse drug events in the oral cavity. Dermatol Clin 2020;38(4):523–33.